W. Dejager

发表

Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus

E. Chakravarty, J. Guthridge, J. Merrill, 2021, Journal of translational autoimmunity.

Adults with systemic lupus exhibit distinct molecular phenotypes in a cross-sectional study

E. Chakravarty, J. Guthridge, J. Merrill, 2020, EClinicalMedicine.

Genetic load in incomplete lupus erythematosus

J. Guthridge, J. James, T. Aberle, 2022, Lupus Science & Medicine.

Ancestry-based differences in the immune system are associated with lupus severity

P. Khatri, H. Maecker, J. Guthridge, 2021 .

Relationship Between a Vitamin D Genetic Risk Score and Autoantibodies Among First-Degree Relatives of Probands With Rheumatoid Arthritis and Systemic Lupus Erythematosus

P. Gaffney, J. Norris, C. Langefeld, 2022, Frontiers in Immunology.

Biomarker panel increases accuracy for identification of an MS relapse beyond sNfL.

G. Pardo, J. Guthridge, Y. Mao-Draayer, 2022, Multiple sclerosis and related disorders.

Disease diagnostics using machine learning of immune receptors

R. Tibshirani, K. Roskin, A. Kundaje, 2022, bioRxiv.

Disease diagnostics using machine learning of immune receptors

R. Tibshirani, K. Roskin, A. Kundaje, 2022, bioRxiv.

A Flare Risk Index Informed by Select Immune Mediators in Systemic Lupus Erythematosus

E. Chakravarty, J. Guthridge, D. Blankenship, 2022, Arthritis & rheumatology.

Disease diagnostics using machine learning of immune receptors

R. Tibshirani, K. Roskin, A. Kundaje, 2022, bioRxiv.

Ancestry-based differences in the immune phenotype are associated with lupus activity

P. Khatri, H. Maecker, J. Guthridge, 2023, JCI insight.

High incidence of proliferative and membranous nephritis in SLE patients with low proteinuria in the Accelerating Medicines Partnership.

K. Kalunian, M. Petri, D. Fine, 2022, Rheumatology.